These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11837513)

  • 21. Cystatin C concentration as a risk factor for heart failure in older adults.
    Sarnak MJ; Katz R; Stehman-Breen CO; Fried LF; Jenny NS; Psaty BM; Newman AB; Siscovick D; Shlipak MG;
    Ann Intern Med; 2005 Apr; 142(7):497-505. PubMed ID: 15809461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystatin-C and mortality in elderly persons with heart failure.
    Shlipak MG; Katz R; Fried LF; Jenny NS; Stehman-Breen C; Newman AB; Siscovick D; Psaty BM; Sarnak MJ
    J Am Coll Cardiol; 2005 Jan; 45(2):268-71. PubMed ID: 15653026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.
    Coll E; Botey A; Alvarez L; Poch E; Quintó L; Saurina A; Vera M; Piera C; Darnell A
    Am J Kidney Dis; 2000 Jul; 36(1):29-34. PubMed ID: 10873868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
    Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
    Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased kidney function in the elderly: clinical and preclinical, neither benign.
    Coresh J; Astor B
    Ann Intern Med; 2006 Aug; 145(4):299-301. PubMed ID: 16908921
    [No Abstract]   [Full Text] [Related]  

  • 26. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients.
    Mazul-Sunko B; Zarković N; Vrkić N; Antoljak N; Bekavac Beslin M; Nikolić Heitzler V; Siranović M; Krizmanić-Dekanić A; Klinger R
    Nephron Clin Pract; 2004; 97(3):c103-7. PubMed ID: 15292687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
    Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation.
    Christensson A; Ekberg J; Grubb A; Ekberg H; Lindström V; Lilja H
    Nephron Physiol; 2003; 94(2):p19-27. PubMed ID: 12845219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
    Damman K; van der Harst P; Smilde TD; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL
    Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
    Akerblom Å; Wallentin L; Siegbahn A; Becker RC; Budaj A; Buck K; Giannitsis E; Horrow J; Husted S; Katus HA; Steg PG; Storey RF; Åsenblad N; James SK
    Clin Chem; 2012 Jan; 58(1):190-9. PubMed ID: 22126936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure.
    Dickstein K; Aarsland T; Hall C
    J Card Fail; 1997 Jun; 3(2):83-9. PubMed ID: 9220307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
    Hall C; Rouleau JL; Moyè L; de Champlain J; Bichet D; Klein M; Sussex B; Packer M; Rouleau J; Arnold MO
    Circulation; 1994 May; 89(5):1934-42. PubMed ID: 8181115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatinine-or cystatin C-based equations to estimate glomerular filtration rate in acute myocardial infarction: a disparity in estimating renal function and in mortality risk prediction.
    Abu-Assi E; Raposeiras-Roubin S; Riveiro-Cruz A; Rodríguez-Girondo M; González-Cambeiro C; Alvarez-Alvarez B; Gestal-Romaní S; Pereira-López E; Cabanas-Grandío P; García-Acuña JM; Virgós-Lamela A; González-Juanatey JR
    Int J Cardiol; 2013 Oct; 168(4):4300-1. PubMed ID: 23714598
    [No Abstract]   [Full Text] [Related]  

  • 37. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
    Shelton RJ; Goode K; Cleland JG
    Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
    [No Abstract]   [Full Text] [Related]  

  • 38. Cystatin C: what more do we need to know?
    Newman DJ
    Nephron Clin Pract; 2003; 93(4):c122-3. PubMed ID: 12759579
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assessing renal function in elderly people].
    Maftei ID; Cepoi V; Covic A
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):27-38. PubMed ID: 17595843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.